New Hampshire Trust’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$266K Buy
2,898
+550
+23% +$48.1K 0.05% 156
2026
Q1
$200K Sell
2,348
-446
-16% -$39.8K 0.04% 156
2025
Q4
$221K Hold
2,794
0.04% 165
2025
Q3
$223K Hold
2,794
0.04% 172
2025
Q2
$254K Hold
2,794
0.05% 171
2025
Q1
$262K Sell
2,794
-1,200
-30% -$107K 0.06% 163
2024
Q4
$363K Hold
3,994
0.08% 137
2024
Q3
$415K Hold
3,994
0.09% 127
2024
Q2
$388K Hold
3,994
0.09% 131
2024
Q1
$360K Sell
3,994
-33
-0.8% -$2.8K 0.08% 133
2023
Q4
$321K Sell
4,027
-612
-13% -$46K 0.08% 138
2023
Q3
$330K Sell
4,639
-233
-5% -$17.4K 0.09% 125
2023
Q2
$375K Hold
4,872
0.1% 121
2023
Q1
$366K Sell
4,872
-137
-3% -$10.2K 0.1% 122
2022
Q4
$395K Buy
+5,009
New +$376K 0.1% 121

Other funds holding CL

New Hampshire Trust's CL Position: Q2 2026 in Review

New Hampshire Trust increased its Colgate-Palmolive (CL) stake by 23% in Q2 2026, buying an estimated $48.1K and bringing the position to 2,898 shares worth $266K. The position accounts for 0.05% of the portfolio, ranked #156.

New Hampshire Trust first reported a position in CL in Q4 2022 and has held it in 15 quarters since. The position peaked at $415K in Q3 2024. 658 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • New Hampshire Trust held 2,898 shares of Colgate-Palmolive worth $266K as of Q2 2026.
  • New Hampshire Trust bought 550 Colgate-Palmolive shares in Q2 2026, an estimated $48.1K.
  • Colgate-Palmolive made up 0.05% of New Hampshire Trust's portfolio in Q2 2026, its #156 holding.
  • New Hampshire Trust first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 15 quarters since.
  • New Hampshire Trust's Colgate-Palmolive position peaked at $415K in Q3 2024.
  • 658 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on New Hampshire Trust's 13F filing for Q2 2026, filed 27 Jul 2026.